Published on November 30, 2023
Exhibit 107
CALCULATION OF FILING FEE TABLE
FORM F-4
(Form type)
FibroBiologics, Inc.
(Exact name of Registrant as specified in its charter)
Table 1: Newly Registered Securities and Carry Forward Securities
Security Type | Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered(1) | Proposed Maximum Offering Price Per Security | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in
Connection with Unsold Securities to be Carried Forward |
|||||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
Fees to be Paid | Equity | Shares of Common Stock, par value $0.00001 per share | 457(d) | 4,806,226 | $ | 15.55 | (2) | $ | 74,736,814 | 0.0001476 | $ | 11,031.15 | — | — | — | — | ||||||||||||||||||||||||||||
Fees Previously Paid | Equity | Shares of Common Stock, par value $0.00001 per share | 457(d) | 4,791,367 | $ | 15.55 | $ | 74,314,102 | 0.0001476 | $ | 10,968.76 | — | — | — | — | |||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 74,736,814 | $ | 10,968.76 | ||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 74,314,102 | $ | 10,968.76 | ||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 62.39 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the Registrant is also registering such additional indeterminate number of ordinary shares as may become issuable as a result of share splits or share dividends. |
(2) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(d) under the Securities Act of 1933, as amended (the “Securities Act”), based on a market value per share reference price of $15.55. |